6 Immunopathogenesis of viral hepatitis

[1]  H. Thomas,et al.  An Analysis of the Composition of the Inflammatory Infiltrate in Autoimmune and Hepatitis B Virus‐Induced Chronic Liver Disease , 2007, Hepatology.

[2]  F. Hsieh,et al.  Efficacy of Hepatitis B Immune Globulin for Prevention of Perinatal Transmission of the Hepatitis B Virus Carrier State: Final Report of a Randomized Double‐Blind, Placebo‐Controlled Trial , 2007, Hepatology.

[3]  F. Chisari,et al.  Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. , 1996, The Journal of clinical investigation.

[4]  M. Houghton,et al.  A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  T. Pilot‐Matias,et al.  Sequence and genomic organization of GBV‐C: A novel member of the flaviviridae associated with human non‐A‐E hepatitis , 1996, Journal of medical virology.

[6]  T. Santantonio,et al.  Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection , 1995, The Lancet.

[7]  F. Chisari,et al.  Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. , 1995, The Journal of clinical investigation.

[8]  T. Pilot‐Matias,et al.  Isolation of novel virus-like sequences associated with human hepatitis , 1995, Nature Medicine.

[9]  A. Hughes,et al.  Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[10]  B. Moss,et al.  The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis , 1995, The Journal of experimental medicine.

[11]  F. Chisari,et al.  Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. , 1995, The Journal of clinical investigation.

[12]  C. Bréchot,et al.  Specific vaccine therapy in chronic hepatitis B infection , 1994, The Lancet.

[13]  F. Chisari,et al.  CTL access to tissue antigen is restricted in vivo. , 1994, Journal of immunology.

[14]  F. Chisari,et al.  Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  F. Chisari,et al.  Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. , 1994, Journal of immunology.

[16]  R. Purcell,et al.  Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses , 1994, Journal of virology.

[17]  F. Chisari,et al.  Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways , 1994, Journal of virology.

[18]  Z. Xiang,et al.  Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. , 1994, Virology.

[19]  B. Walker,et al.  Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV , 1993, Journal of virology.

[20]  H. Davis,et al.  DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. , 1993, Human molecular genetics.

[21]  V. Srikantan,et al.  DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. , 1993, DNA and cell biology.

[22]  M. Houghton,et al.  Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. , 1993, Journal of immunology.

[23]  W. Ching,et al.  B‐cell epitopes on the hepatitis C virus nucleocapsid protein determined by human monospecific antibodies , 1993, Hepatology.

[24]  M. Houghton,et al.  Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C , 1993, The Journal of experimental medicine.

[25]  P. Simmonds,et al.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3 , 1993, Journal of clinical microbiology.

[26]  A. Vitiello,et al.  HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. , 1993, Journal of immunology.

[27]  Bin Wang,et al.  Gene inoculation generates immune responses against human immunodeficiency virus type 1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. Matsumoto,et al.  Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens , 1993, Journal of clinical microbiology.

[29]  J. Ulmer,et al.  Heterologous protection against influenza by injection of DNA encoding a viral protein. , 1993, Science.

[30]  F. Chisari,et al.  HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis , 1993, The Journal of experimental medicine.

[31]  M A Gerber,et al.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. , 1992, The New England journal of medicine.

[32]  W. Carman,et al.  Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. , 1992, The Journal of clinical investigation.

[33]  B. Walker,et al.  Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. , 1992, Journal of immunology.

[34]  M. Nassal.  The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly , 1992, Journal of virology.

[35]  F. Chisari,et al.  Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice , 1992, Journal of virology.

[36]  F. Chisari,et al.  Hepatitis B virus (HBV)-specific cytotoxic T-cell response in humans: production of target cells by stable expression of HBV-encoded proteins in immortalized human B-cell lines , 1992, Journal of virology.

[37]  C. Peschle,et al.  Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes , 1992, The Journal of experimental medicine.

[38]  B. Moss,et al.  Hepatitis B virus (HBV)-specific cytotoxic T-cell (CTL) response in humans: characterization of HLA class II-restricted CTLs that recognize endogenously synthesized HBV envelope antigens , 1992, Journal of virology.

[39]  F. Chisari,et al.  HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. W. Tam,et al.  Hepatitis E virus (HEV): Molecular cloning and sequencing of the full-length viral genome , 1991, Virology.

[41]  M. Mondelli,et al.  Identification of an immunodominant B cell epitope on the hepatitis C virus nonstructural region defined by human monoclonal antibodies. , 1991, Journal of immunology.

[42]  F. Chisari,et al.  Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. , 1991, The Journal of clinical investigation.

[43]  P. Tiollais,et al.  Hepatitis B virus. , 1991, Scientific American.

[44]  S. Hadler,et al.  Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. , 1991, The Journal of infectious diseases.

[45]  S. Eckhardt,et al.  Hepatitis B virus core antigen has two nuclear localization sequences in the arginine-rich carboxyl terminus , 1991, Journal of virology.

[46]  A Valli,et al.  Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. , 1990, Journal of immunology.

[47]  G. Fattovich,et al.  Antibodies to the RNase H domain of hepatitis B virus P protein are associated with ongoing viral replication , 1990, Journal of virology.

[48]  A. Zuckerman,et al.  Vaccine-induced escape mutant of hepatitis B virus , 1990, The Lancet.

[49]  D. Burns,et al.  Extrahepatic hepatitis B virus DNA sequences in patients with acute hepatitis B infection , 1990, Hepatology.

[50]  A. Kasahara,et al.  Detection of antibodies against the polymerase gene product in hepatitis B virus infection , 1990, Hepatology.

[51]  H. Will,et al.  Immunogenicity of human hepatitis B virus P-gene derived proteins. , 1989, Journal of immunology.

[52]  P. Ashton‐Rickardt,et al.  Mutants of the hepatitis b virus surface antigen that define some antigenically essential residues in the immunodominant a region , 1989, Journal of medical virology.

[53]  V. Barnaba,et al.  Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. , 1989, Journal of immunology.

[54]  H. Varmus,et al.  Detection of antibodies against hepatitis B virus polymerase antigen in hepatitis B virus‐infected patients , 1989, Hepatology.

[55]  D. Bradley,et al.  Enterically transmitted non-A, non-B hepatitis: identification of virus-associated antigen in experimentally infected cynomolgus macaques. , 1989, The Journal of infectious diseases.

[56]  F. Chisari,et al.  Hepatitis B virus structure and biology. , 1989, Microbial pathogenesis.

[57]  M. Houghton,et al.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.

[58]  S. Jonjić,et al.  Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes , 1989, The Journal of experimental medicine.

[59]  R. Purcell,et al.  Natural history of woodchuck hepatitis virus infections during the course of experimental viral infection: molecular virologic features of the liver and lymphoid tissues , 1989, Journal of virology.

[60]  G. Duncan,et al.  Presence of antibodies to the polymerase gene product(s) of hepatitis B and woodchuck hepatitis virus in natural and experimental infections , 1988, Journal of medical virology.

[61]  H. Dienes,et al.  Immunoelectron microscopic observations on the inflammatory infiltrates and HLA antigens in hepatitis B and non‐A, Non‐B , 1987, Hepatology.

[62]  V. Lingappa,et al.  Multiple topogenic sequences determine the transmembrane orientation of the hepatitis B surface antigen , 1987, Molecular and cellular biology.

[63]  A. Dejean,et al.  The hepatitis B virus , 1985, Nature.

[64]  P. Pontisso,et al.  Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[65]  V. Desmet,et al.  Interdigitating and dendritic reticulum cells in chronic active hepatitis , 1984, Histopathology.

[66]  A. Dejean,et al.  Detection of hepatitis B virus DNA in pancreas, kidney and skin of two human carriers of the virus. , 1984, The Journal of general virology.

[67]  A. Haase,et al.  Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium, and vascular elements by in situ hybridization. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[68]  P. Mortimer,et al.  The value of screening blood donors for antibody to hepatitis B core antigen. , 1983, Journal of clinical pathology.

[69]  R. Williams,et al.  Immunohistochemical characterization of hepatic tissue lymphocyte subpopulations in liver disease. , 1982, Scandinavian journal of gastroenterology.

[70]  S. Poppema,et al.  CELLULAR AND HUMORAL IMMUNE-REACTIONS IN CHRONIC ACTIVE LIVER-DISEASE .1. LYMPHOCYTE SUBSETS IN LIVER BIOPSIES OF PATIENTS WITH UNTREATED IDIOPATHIC AUTOIMMUNE HEPATITIS, CHRONIC ACTIVE HEPATITIS-B AND PRIMARY BILIARY-CIRRHOSIS , 1982 .

[71]  B D Hall,et al.  Synthesis and assembly of hepatitis B virus surface antigen particles in yeast , 1982, Nature.

[72]  Kazuaki Takahashi,et al.  Maternofetal Transmission of IgG-Bound Hepatitis B e Antigen , 1982, Pediatric Research.

[73]  J. Wands,et al.  Hepatitis B in an oncology unit. , 1974, The New England journal of medicine.

[74]  M. K. Mann,et al.  Hepatitis B infection. A point-prevalence study in 15 US hemodialysis centers. , 1974 .

[75]  F. Chisari,et al.  Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. , 1996, Immunity.

[76]  A. Varki.  The times they are still a'changing: keeping up with the times. , 1996, The Journal of clinical investigation.

[77]  A. Vitiello,et al.  Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. , 1995, The Journal of clinical investigation.

[78]  E. Ciccone,et al.  Human natural killer cells: origin, clonality, specificity, and receptors. , 1994, Advances in immunology.

[79]  S. Lemon,et al.  Viral Hepatitis and Liver Disease , 1994, Springer Japan.

[80]  J. Sung,et al.  Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. , 1992, The Journal of clinical investigation.

[81]  A. Zuckerman,et al.  Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. , 1991, Journal of hepatology.

[82]  R. Fernandez-Botran,et al.  Cellular interactions in the humoral immune response. , 1989, Advances in immunology.

[83]  F. Carnot,et al.  Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients. A prospective study of 90 patients. , 1988, Gastroenterology.

[84]  H. Thomas,et al.  Effect of human immunodeficiency virus (HIV) infection on chronic hepatitis B hepatic viral antigen display. , 1987, Journal of hepatology.

[85]  J. Hoofnagle,et al.  Viral hepatitis and liver disease , 1984 .

[86]  J. M. Morrison,et al.  Hepatitis B Vaccine , 1980, The Lancet.